| Dr Andrew Rudins, MD | |
|
21 Turtle Creek Dr, Asheville, NC 28803-3152 | |
| (828) 274-4555 | |
| (828) 274-8348 |
| Full Name | Dr Andrew Rudins |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 36 Years |
| Location | 21 Turtle Creek Dr, Asheville, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851486542 | NPI | - | NPPES |
| 27671 | Other | NC | MEDCOST PROVIDER NUMBER |
| 891060K | Medicaid | NC | |
| 1060K | Other | NC | BCBS OF NC PROVIDER NUMBE |
| 250010858 | Other | NC | RR MEDICARE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Margaret R Pardee Memorial Hospital | Hendersonville, NC | Hospital |
| Haywood Regional Medical Center | Clyde, NC | Hospital |
| Entity Name | Henderson County Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447444559 PECOS PAC ID: 8123938115 Enrollment ID: O20040611001396 |
News Archive
Sepsis represents a serious complication of infection and is one of the leading causes of death and critical illness worldwide due in part to the lack of effective therapies. A report in the American Journal of Pathology provides evidence from both mouse and human studies that SHARPIN, a protein involved in regulating inflammation, has anti-septic effects. These findings may spur development of novel sepsis treatments.
Amorfix Life Sciences and QED Bioscience announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Under the agreement, QED will generate monoclonal antibodies against several disease specific epitopes on misfolded CD38 protein. The DSE's were identified by Amorfix using their proprietary ProMIS computational platform discovery technology.
Using computational modeling, researchers at Carnegie Mellon University, the Colorado School of Mines and the University of California, Davis have come up with a design for a better liposome. Their findings, while theoretical, could provide the basis for efficiently constructing new vehicles for nanodrug delivery.
A new brain imaging study may help explain why people with insomnia often complain that they struggle to concentrate during the day even when objective evidence of a cognitive problem is lacking.
Poll results released today by charity Fight for Sight highlight that many Brits are frequently putting their eyesight at risk through unsafe contact lens habits, unaware that these could lead to a painful and sight-threatening eye infection called Acanthamoeba keratitis.
› Verified 9 days ago
| Entity Name | Henderson County Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053782318 PECOS PAC ID: 8123938115 Enrollment ID: O20160201002874 |
News Archive
Sepsis represents a serious complication of infection and is one of the leading causes of death and critical illness worldwide due in part to the lack of effective therapies. A report in the American Journal of Pathology provides evidence from both mouse and human studies that SHARPIN, a protein involved in regulating inflammation, has anti-septic effects. These findings may spur development of novel sepsis treatments.
Amorfix Life Sciences and QED Bioscience announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Under the agreement, QED will generate monoclonal antibodies against several disease specific epitopes on misfolded CD38 protein. The DSE's were identified by Amorfix using their proprietary ProMIS computational platform discovery technology.
Using computational modeling, researchers at Carnegie Mellon University, the Colorado School of Mines and the University of California, Davis have come up with a design for a better liposome. Their findings, while theoretical, could provide the basis for efficiently constructing new vehicles for nanodrug delivery.
A new brain imaging study may help explain why people with insomnia often complain that they struggle to concentrate during the day even when objective evidence of a cognitive problem is lacking.
Poll results released today by charity Fight for Sight highlight that many Brits are frequently putting their eyesight at risk through unsafe contact lens habits, unaware that these could lead to a painful and sight-threatening eye infection called Acanthamoeba keratitis.
› Verified 9 days ago
| Entity Name | Prime Nc Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295390557 PECOS PAC ID: 4587994207 Enrollment ID: O20190924000307 |
News Archive
Sepsis represents a serious complication of infection and is one of the leading causes of death and critical illness worldwide due in part to the lack of effective therapies. A report in the American Journal of Pathology provides evidence from both mouse and human studies that SHARPIN, a protein involved in regulating inflammation, has anti-septic effects. These findings may spur development of novel sepsis treatments.
Amorfix Life Sciences and QED Bioscience announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Under the agreement, QED will generate monoclonal antibodies against several disease specific epitopes on misfolded CD38 protein. The DSE's were identified by Amorfix using their proprietary ProMIS computational platform discovery technology.
Using computational modeling, researchers at Carnegie Mellon University, the Colorado School of Mines and the University of California, Davis have come up with a design for a better liposome. Their findings, while theoretical, could provide the basis for efficiently constructing new vehicles for nanodrug delivery.
A new brain imaging study may help explain why people with insomnia often complain that they struggle to concentrate during the day even when objective evidence of a cognitive problem is lacking.
Poll results released today by charity Fight for Sight highlight that many Brits are frequently putting their eyesight at risk through unsafe contact lens habits, unaware that these could lead to a painful and sight-threatening eye infection called Acanthamoeba keratitis.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrew Rudins, MD Po Box 1869, Fletcher, NC 28732-1869 Ph: (828) 687-6282 | Dr Andrew Rudins, MD 21 Turtle Creek Dr, Asheville, NC 28803-3152 Ph: (828) 274-4555 |
News Archive
Sepsis represents a serious complication of infection and is one of the leading causes of death and critical illness worldwide due in part to the lack of effective therapies. A report in the American Journal of Pathology provides evidence from both mouse and human studies that SHARPIN, a protein involved in regulating inflammation, has anti-septic effects. These findings may spur development of novel sepsis treatments.
Amorfix Life Sciences and QED Bioscience announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Under the agreement, QED will generate monoclonal antibodies against several disease specific epitopes on misfolded CD38 protein. The DSE's were identified by Amorfix using their proprietary ProMIS computational platform discovery technology.
Using computational modeling, researchers at Carnegie Mellon University, the Colorado School of Mines and the University of California, Davis have come up with a design for a better liposome. Their findings, while theoretical, could provide the basis for efficiently constructing new vehicles for nanodrug delivery.
A new brain imaging study may help explain why people with insomnia often complain that they struggle to concentrate during the day even when objective evidence of a cognitive problem is lacking.
Poll results released today by charity Fight for Sight highlight that many Brits are frequently putting their eyesight at risk through unsafe contact lens habits, unaware that these could lead to a painful and sight-threatening eye infection called Acanthamoeba keratitis.
› Verified 9 days ago
Kathryn Marie Alfonso, DO Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 123 Hendersonville Rd, Asheville, NC 28803 Phone: 828-257-4730 Fax: 828-232-2942 | |
Dr. Edgardo Diez, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 68 Sweeten Creek Rd, Asheville, NC 28803 Phone: 828-277-4805 Fax: 828-274-6145 | |
Christie M Lehman, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1257 Hendersonville Rd, Ste A, Asheville, NC 28803 Phone: 828-649-6265 | |
Kristen Frances Anderson, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1100 Tunnel Rd, Asheville, NC 28805 Phone: 828-298-7911 | |
Fenella Sofia Roche, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1100 Tunnel Rd, Asheville, NC 28805 Phone: 802-274-2880 | |
Jennifer Jacobson, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2360 Sweeten Creek Rd, Asheville, NC 28803 Phone: 828-274-4800 | |
Austin John Hille, CAT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 400 Landis Ct. #203, Asheville, NC 28806 Phone: 954-918-2124 |